Meta-analysis of randomized clinical trials in the era of individual patient data sharing

摘要

BackgroundIndividual patient data (IPD) meta-analysis is considered to be a gold standard when the results of several randomized trials are combined. Recent initiatives on sharing IPD from clinical trials offer unprecedented opportunities for using such data in IPD meta-analyses.